Ledger.Open graph →
SEC Form D · filed July 25, 2025

DiaMedica Therapeutics Inc

Offering
$30.1M
Sold
$30.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MINNEAPOLIS, MN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

David J. Wambeke · Minneapolis, MNExecCharles P. Semba · MINNEAPOLIS, MNDirectorTanya N. Lewis · Minneapolis, MNDirectorJames T. Parsons · MINNEAPOLIS, MNDirectorLorianne Masuoka · Minneapolis, MNExecDaniel T. O'Connor · Minneapolis, MNDirectorScott Kellen · Minneapolis, MNExecRichard R. Kuntz · Minneapolis, MNDirectorMichael R. Giuffre · Minneapolis, MNDirectorRick Pauls · Minneapolis, MNExec · DirectorDavid J. Wambeke · Minneapolis, MNExecCharles P. Semba · MINNEAPOLIS, MNDirectorLorianne Masuoka · Minneapolis, MNExecDaniel T. O'Connor · Minneapolis, MNDirectorScott Kellen · Minneapolis, MNExecRichard R. Kuntz · Minneapolis, MNDirectorMichael R. Giuffre · Minneapolis, MNDirectorTanya N. Lewis · Minneapolis, MNDirectorRick Pauls · Atlanta, GAExec · DirectorJames T. Parsons · MINNEAPOLIS, MNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗